- Nachrichtendetail
-
18.04.2024 14:38:37 - dpa-AFX: *ABBVIE'S PHASE 3 STUDY OF UPADACITINIB SHOWS POSITIVE RESULTS IN GIANT CELL ARTERITIS PATIENTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
ABBVIE INC. DL-,01 | A1J84E | Frankfurt | 173,800 | 23.09.24 17:39:09 | +0,740 | +0,43% | 173,440 | 174,000 | 174,440 | 173,060 |
